ASCENTAGE PHARMA GROUP INTL
CUSIP: 04390B105
ASCENTAGE PHARMA GROUP INTL (AAPG) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
Ascentage Pharma Group International is a clinical-stage biopharmaceutical company developing targeted small-molecule therapies for oncology and other serious diseases. The company emphasizes drug discovery around apoptosis and protein homeostasis pathways and maintains a pipeline of preclinical and clinical-stage candidates. Headquartered with research and development operations in Asia and the U.S., Ascentage focuses on advancing investigational programs and collaborations to address unmet medical needs in cancer and related areas.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
Try asking...